Latest Joslin Stories
BOSTON, March 31, 2011 /PRNewswire/ -- Joslin Diabetes Center has appointed John L.
New collaboration leverages Joslin's deep clinical and research expertise and dLife's community and lifestyle approach to managing diabetes. BOSTON, Jan.
A multicenter international study chaired by a Joslin Diabetes Center investigator and reported in the July issue of the American Diabetes Associationâ€™s journal Diabetes brings hopeful news to the 18 million people in the United States â€” and millions more worldwide â€” with type 1 or type 2 diabetes. Initial results of the Phase III clinical trial demonstrated that 32 milligrams per day of ruboxistaurin (RBX) was well tolerated and may reduce the risk of moderate vision...
Study showing role of PKC-beta 2 in diabetic complications to be presented at the American Diabetes Association 65th Scientific Sessions in San Diego.